The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been endorsed by the ANZCTR. Before participating in a study, talk to your health care provider and refer to this information for consumers
Trial details imported from ClinicalTrials.gov

For full trial details, please see the original record at https://clinicaltrials.gov/study/NCT07059754




Registration number
NCT07059754
Ethics application status
Date submitted
29/03/2025
Date registered
11/07/2025
Date last updated
11/07/2025

Titles & IDs
Public title
A Clinical Study to Determine What Effect the EyeCool Treatment Has on the Eye's Surface Anatomy and Inflammation Response After Being Treated for Having Chronic Ocular Surface Pain (COSP)
Scientific title
A Prospective, Feasibility, Single-Center, Clinical Study to Evaluate the Effect of the ETX-4143 Topical Ophthalmic Cooling Device on Ocular Surface Structures and Cell Population in Patients With Chronic Ocular Surface Pain
Secondary ID [1] 0 0
ETX4143-A005
Universal Trial Number (UTN)
Trial acronym
Linked study record

Health condition
Health condition(s) or problem(s) studied:
Eye Pain 0 0
Condition category
Condition code
Eye 0 0 0 0
Diseases / disorders of the eye

Intervention/exposure
Study type
Interventional
Description of intervention(s) / exposure
Treatment: Devices - Topical Ophthalmic Cooling

Experimental: Interventional - Eyes that are treated with the ETX-4143 topical ophthalmic cooling device


Treatment: Devices: Topical Ophthalmic Cooling
Targeted topical ophthalmic cooling treatment using the ETX-4143 cooling device

Intervention code [1] 0 0
Treatment: Devices
Comparator / control treatment
Control group

Outcomes
Primary outcome [1] 0 0
Corneal Confocal In-vivo Microscopy Image Analysis
Timepoint [1] 0 0
From treatment to the end of twelve weeks

Eligibility
Key inclusion criteria
* Documented symptoms of COSP pain for at least 3 months
* A score of =5 on the single question COP-Q Eye Pain Severity Module
* Able to obtain sufficient quality corneal in-vivo confocal microscopy images
Minimum age
22 Years
Maximum age
90 Years
Sex
Both males and females
Can healthy volunteers participate?
No
Key exclusion criteria
* Less than 50% improvement in VAS Eye Pain score after topical 0.5% proparacaine hydrochloride at screening
* Subjects with clinically significant corneal scarring that could limit the confocal microscopy
* Insufficient number of corneal nerves to permit Fun-IVCM imaging

Study design
Purpose of the study
Treatment
Allocation to intervention
Not applicable
Procedure for enrolling a subject and allocating the treatment (allocation concealment procedures)
Methods used to generate the sequence in which subjects will be randomised (sequence generation)
Masking / blinding
Open (masking not used)
Who is / are masked / blinded?



Intervention assignment
Single group
Other design features
Phase
Not applicable
Type of endpoint/s
Statistical methods / analysis

Recruitment
Recruitment status
Recruiting
Data analysis
Reason for early stopping/withdrawal
Other reasons
Date of first participant enrolment
Anticipated
Actual
Date of last participant enrolment
Anticipated
Actual
Date of last data collection
Anticipated
Actual
Sample size
Target
Accrual to date
Final
Recruitment in Australia
Recruitment state(s)
VIC
Recruitment hospital [1] 0 0
Sunshine Eye Surgeons - Melbourne
Recruitment postcode(s) [1] 0 0
3021 - Melbourne

Funding & Sponsors
Primary sponsor type
Commercial sector/industry
Name
EyeCool Therapeutics, Inc.
Address
Country

Ethics approval
Ethics application status

Summary
Brief summary
Trial website
Trial related presentations / publications
Public notes

Contacts
Principal investigator
Name 0 0
Patrick Casey R VP of Clinical Development, Optometrist
Address 0 0
EyeCool Therapeutics, Inc.
Country 0 0
Phone 0 0
Fax 0 0
Email 0 0
Contact person for public queries
Name 0 0
Patrick Casey, Optometrist
Address 0 0
Country 0 0
Phone 0 0
15104100543
Fax 0 0
Email 0 0
Contact person for scientific queries

Data sharing statement
Will individual participant data (IPD) for this trial be available (including data dictionaries)?
No
No/undecided IPD sharing reason/comment


What supporting documents are/will be available?

No Supporting Document Provided


Results publications and other study-related documents

No documents have been uploaded by study researchers.